Abstract
Nociceptin (N/OFQ) is involved in neuronal excitability and in certain types of seizures. Kainate-induced seizures are associated with increased N/OFQ release in the rat thalamus and hippocampus, causing down-regulation of the N/OFQ receptor (NOP). In this study, we used the neuroblastoma SH-SY5Y cell line as a model to investigate the effects of kainate on NOP receptor density and gene expression. Exposure to kainate (10–50 μM) for 3 h did not affect NOP receptor density. In contrast, a NOP B max down-regulation was detected in cells exposed to 10 μM kainate for both 6 and 24 h. Moreover, our data show that kainate causes a decrease in NOP mRNA levels after 3, 6, and 24 h, an effect blocked by the AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). These findings show that kainate is able to affect the NOP system, both at biosynthesis and receptor density levels in SH-SY5Y cells, and that the kainate ionotropic receptor can contribute to the regulation of the NOP receptor. These data are in agreement with data obtained in vivo and provide new evidence concerning the existence of a cross-talk between NOP and kainate receptors, leading to an interplay between glutamate and N/OFQ circuits.
Similar content being viewed by others
Abbreviations
- N/OFQ:
-
nociceptin
- CNQX:
-
6-cyano-7-nitroquinoxaline-2,3-dione
References
Aparicio, L. C., Candeletti, S., Binaschi, A., Mazzuferi, M., Mantovani, S., Di Benedetto, M., et al. (2004). Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study. Journal of neurochemistry, 91, 30–7.
Ben, L. H., Zhao, J., Xin, S. M., Luo, S. Q., & Pei, G. (1999). Attenuation of delta opioid receptor-mediated signaling by kainic acid in neural cells: involvement of protein kinase C and intracellular Ca2 +. Neuropharmacology, 38, 991–8.
Bregola, G., Candeletti, S., Romualdi, P., & Simonato, M. (1999). Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. NeuroReport, 10, 541–546.
Bregola, G., Zucchini, S., Rodi, D., Binaschi, A., D’Addario, C., Landuzzi, D., et al. (2002). Involvement of the neuropeptide Nociceptin/orphanin FQ in kainate seizures. Journal of neuroscience, 22, 10030–8.
Chomczynski, P., & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical biochemistry, 162, 156–9.
Ciccocioppo, R., Angeletti, S., Panocka, I., & Massi, M. (2000). Nociceptin/orphanin FQ and drugs of abuse. Peptides, 21, 1071–80.
Ciccocioppo, R., Martin-Fardon, R., Weiss, F., & Massi, M. (2001). Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. Neuroreport, 12, 1145–9.
Connor, M., Yeo, A., & Henderson, G. (1996). The effect of nociceptin on Ca2 + channel current and intracellular Ca2 + in the SH-SY5Y human neuroblastoma cell line. British Journal of Pharmacology, 118, 205–7.
Cox, B. M., Chavkin, C., Christie, M. J., Civelli, O., Evans, C., Hamon, M. D., et al. (2000). Opioid receptors. In D. Girdlestone (Ed.) The IUPHAR compendium of receptor characterization and classification (pp. 321–333). London: IUPHAR Media.
Douglass, J., Grimes, L., Shook, J., Lee, P. H., & Hong, J. S. (1991). Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptides in the rat hippocampus. Brain Res. Mol. Brain Res, 9, 79–86.
Hong, J. S., McGinty, J. F., Lee, P. H., Xie, C. W., & Mitchell, C. L. (1993). Relationship between hippocampal opioid peptides and seizures. Progress in neurobiology, 40, 507–28.
Jenck, F., Moreau, J. L., Martin, J. R., Kilpatrick, G. J., Reinscheid, R. K., Monsma, F. J., et al. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proceedings of the National Academy of Sciences of the United States of America, 94, 14854–14858.
Kew, J. N. C., & Kemp, J. A. (2005). Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology, 179, 4–29.
Liu, H., Gao, H. M., Zhang, W. Q., Tang, Y. Y., & Song, H. S. (2004). Effect of chronic administration of PL017 and beta-funaltrexamine hydrochloride on susceptibility of kainic acid-induced seizures in rats. Sheng Li Xue Bao, 56, 101–106.
Lowry, O. H., Rosenbrough, N. J., Farra, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of biological chemistry, 193, 265–75.
Manabe, T., Noda, Y., Mamiya, T., Katagiri, H., Houtani, T., Nishi, M., et al. (1998). Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature, 394, 577–581.
Meis, S., & Pape, H. C. (2001). Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. Journal of physiology, 532, 701–12.
Meunier, J. C., Mollereau, C., Toll, L., Suaudeau, C., Moisand, C., Alvinerie, P., et al. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532–53.
Mollereau, C., Parmentier, M., Mailleux, P., Butour, J. L., Moisand, C., Chalon, P., et al. (1994). ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS letters, 341, 33–38.
Mossmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and citotoxicity assay. Journal of immunological methods, 65, 55–63.
Nicol, B., Lambert, D. G., Rowbotham, D. J., Smart, D., & McKnight, A. T. (1996). Nociceptin induced inhibition of K + evoked glutamate release from rat cerebrocortical slices. British Journal of Pharmacology, 119, 1081–3.
Reinscheid, R. K., Nothacker, H. P., Bourson, A., Ardati, A., Henningsen, R. A., Bunzow, J. R., et al. (1995). Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science, 270, 792–794.
Rocha, L., & Maidment, N. T. (2003). Opioid peptide release in the rat hippocampus after kainic acid-induced status epilepticus. Hippocampus, 13, 472–80.
Sandin, J., Georgieva, J., Schott, P. A., Ogren, S. O., & Terenius, L. (1997). Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. European journal of neuroscience, 9, 194–197.
Schlicker, E., Werthwein, S., Kathmann, M., & Bauer, U. (1998). Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn Schmiedebergs Arch. Pharmacol, 358, 418–22.
Skyers, P. S., Einheber, S., Pierce, J. P., & Milner, T. A. (2003). Increased mu-opioid receptor labeling is found on inner molecular layer terminals of the dentate gyrus following seizures. Experimental neurology, 179, 200–9.
Simmons, M. L., & Chavkin, C. (1996). Endogenous opioid regulation of hippocampal function. International review of neurobiology, 39, 145–96.
Simonato, M., & Romualdi, P. (1996). Dynorphin and epilepsy. Progress in neurobiology, 50, 557–83.
Siniscalchi, A., Rodi, D., Beani, L., & Bianchi, C. (1999). Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices. British Journal of Pharmacology, 128, 119–123.
Thakker, D. R., & Standifer, K. M. (2002). Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure. Neuropharmacology, 43, 979–90.
Tian, J. H., Zhang, W., Fang, Y., Xu, W., Grandy, D. K., & Han, J. S. (1998). Endogenous orphanin FQ: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. British Journal of Pharmacology, 124, 21–26.
Tortella, F. C. (1988). Endogenous opioid peptides and epilepsy: quieting the seizing brain. Trends in pharmacological sciences, 9, 366–72.
Acknowledgement
The authors wish to thank Dr. Gabriele Campana for his helpful technical suggestions. This study was supported by grants from the Italian Ministry for the University and Scientific Research (PRIN 2006–2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Cannarsa and Landuzzi contributed equally to this work.
Rights and permissions
About this article
Cite this article
Cannarsa, R., Landuzzi, D., Cavina, C. et al. Kainic Acid Down-regulates NOP Receptor Density and Gene Expression in Human Neuroblastoma SH-SY5Y Cells. J Mol Neurosci 35, 171–177 (2008). https://doi.org/10.1007/s12031-008-9038-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-008-9038-x